James Bolling

Process Development Engineer II

James is a part of the Cell Therapy team at Precision BioSciences focused on process development for allogeneic CAR-T products. He comes to Precision from MedImmune, where he led the upstream process development of multiple therapeutic monoclonal antibody products and, more recently, adoptive T cell therapies. James specializes in T-Cell activation, viral transduction and bioreactor process optimization. Prior to MedImmune, James received his MS in Biotechnology from the McCormick School of Engineering at Northwestern University and he holds Bachelor’s Degrees in Biology and Economics from the University of Virginia. When James is not disentangling tubing sets in the lab, he enjoys spending time outside – running, skiing and playing golf, and cheering on the Wahoos with his wife.